Don't Think of Corlanor as a Replacement for Beta-Blockers for Heart Failure

June 2015

Corlanor (CORE-lah-nore, ivabradine) will be the first new drug approved for systolic heart failure in a decade.

It works by inhibiting the I_f or "funny" current in the sinoatrial node. This lowers heart rate...withOUT causing a drop in blood pressure.

Ivabradine prevents 1 in 25 patients from being hospitalized over 2 years...when ADDED to an ACEI or ARB, beta-blocker, and aldosterone antagonist. But it DOESN'T reduce overall mortality.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Cardiology Don't Think of Corlanor as a Replacement for Beta-Blockers for Heart Failure
Women's Health Explain When Back-Up Contraception is NOT Needed with Antibiotics
Asthma Consider a Dry-Powder Albuterol Inhaler if an MDI Poses Problems
Infectious Diseases Continue to Cover for Atypicals in Hospitalized Pneumonia Patients
Diabetes Choose Metformin Add-Ons Based on Their Pros and Cons
Constipation Don't Count on Stool Softeners to Help Opioid-Induced Constipation
Interactions Watch for Interactions Between Amiodarone and Hep C Meds
Substance Use Disorder Be Aware Adult Beverages Now Come "Ready for Reconstitution"
Hypertension Use a Beta-Blocker in CAD Patients with Hypertension
Coupons & Discounts Think Twice Before Giving Out Free Drug Coupons
Sunscreens Debunk Myths About Sunscreens
Substance Use Disorder Consider Pill Reminder Apps for Teenagers

Don't Think of Corlanor as a Replacement for Beta-Blockers for Heart Failure

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents